Baricitinib Plus Glucocorticoid for Eosinophilia in IgG4-RD
Condition(s):IgG4-related Disease With EosinophiliaLast Updated:March 27, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):IgG4-related Disease With EosinophiliaLast Updated:March 27, 2023Recruiting
Condition(s):HealthyLast Updated:December 6, 2023Recruiting
Condition(s):Severe PneumoniaLast Updated:March 14, 2023Recruiting
Condition(s):Local Anesthetic; Ultrasound; Pain, AcuteLast Updated:December 22, 2023Recruiting
Condition(s):Acute Tubulo-Interstitial NephritisLast Updated:December 30, 2020Recruiting
Condition(s):Pneumonitis; Malignant TumorLast Updated:March 15, 2022Recruiting
Condition(s):Sjogren Syndrome With Other Organ InvolvementLast Updated:January 23, 2023Not yet recruiting
Condition(s):Meniere DiseaseLast Updated:December 4, 2023Recruiting
Condition(s):Facial Palsy; Facial Nerve Diseases; Borrelia Infection of Central Nervous System; Bell PalsyLast Updated:October 31, 2023Recruiting
Condition(s):Cardiac Sarcoidosis; SarcoidosisLast Updated:July 25, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.